These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10165108)

  • 1. Management of thyroid ophthalmopathy.
    Kraus DJ
    Curr Opin Ophthalmol; 1996 Oct; 7(5):54-9. PubMed ID: 10165108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Graves' ophthalmopathy: reality and perspectives.
    Bartalena L; Pinchera A; Marcocci C
    Endocr Rev; 2000 Apr; 21(2):168-99. PubMed ID: 10782363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM
    Thyroid; 1995 Jun; 5(3):231-4. PubMed ID: 7580273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid and the eye.
    Chavis PS
    Curr Opin Ophthalmol; 2002 Dec; 13(6):352-6. PubMed ID: 12441836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe endocrine ophthalmopathy. A review with case reports].
    Barth A; Bosshard C; Bürgi U; Bürgi H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):3-9. PubMed ID: 1899292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy.
    Yeatts RP
    Med Clin North Am; 1995 Jan; 79(1):195-209. PubMed ID: 7808092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for Graves' ophthalmopathy.
    Bartley GB; Gorman CA
    Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into pathogenesis and potential therapeutic options for Graves orbitopathy.
    Warwar RE
    Curr Opin Ophthalmol; 1999 Oct; 10(5):358-61. PubMed ID: 10621552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Graves' ophthalmopathy in pregnancy.
    Stafford IP; Dildy GA; Miller JM
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1221-3. PubMed ID: 15863589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves ophthalmopathy.
    Bradley EA
    Curr Opin Ophthalmol; 2001 Oct; 12(5):347-51. PubMed ID: 11588496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of 3-stage treatment: (I) corticotherapy, (II) linear acceleration and (III) orbital decompression in 206 patients with malignant Graves ophthalmopathy].
    Zgliczyński S; Jastrzebska H; Górowski T; Janik J; Kuś J; Hliniak A; Karczmarzyk R; Kukołowicz P
    Endokrynol Pol; 1992; 43(3):274-86. PubMed ID: 1345567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prevention of Graves' ophthalmopathy.
    Wiersinga WM; Bartalena L
    Thyroid; 2002 Oct; 12(10):855-60. PubMed ID: 12487767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
    Choi SW; Lee JY; Lew H
    Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
    Gopinath B; Ma G; Wall JR
    Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey.
    Weetman AP; Wiersinga WM
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):21-8. PubMed ID: 9797843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.